rs310229
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002227.4(JAK1):c.1459-7C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.324 in 1,606,088 control chromosomes in the GnomAD database, including 88,904 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002227.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAK1 | NM_002227.4 | c.1459-7C>T | splice_region_variant, intron_variant | ENST00000342505.5 | NP_002218.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAK1 | ENST00000342505.5 | c.1459-7C>T | splice_region_variant, intron_variant | 5 | NM_002227.4 | ENSP00000343204.4 |
Frequencies
GnomAD3 genomes AF: 0.399 AC: 60592AN: 151784Hom.: 13198 Cov.: 32
GnomAD3 exomes AF: 0.359 AC: 87990AN: 245004Hom.: 16993 AF XY: 0.347 AC XY: 46218AN XY: 133046
GnomAD4 exome AF: 0.316 AC: 459018AN: 1454186Hom.: 75660 Cov.: 32 AF XY: 0.314 AC XY: 227173AN XY: 722518
GnomAD4 genome AF: 0.400 AC: 60699AN: 151902Hom.: 13244 Cov.: 32 AF XY: 0.399 AC XY: 29660AN XY: 74250
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 68% of patients studied by a panel of primary immunodeficiencies. Number of patients: 65. Only high quality variants are reported. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at